Anti-Mouse CD252 (RM134L) In Vivo Antibody - Low Endotoxin

In stock
Only %1 left
SKU
ICH1228
Add to Compare
$390.00
Add to Wish List
More Information
Concentration ≥ 2.0 mg/ml
isotype Rat IgG2b kappa
Host Rat
Target CD252
Species Reactivity Mouse
Purification Method This monoclonal antibody was purified using Protein G
Formulation This antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (PBS) pH 7.2, 150 mM NaCl with no carrier protein, potassium or preservatives added.
Purity >95% by SDS-PAGE and HPLC
Endotoxin ≤ 1.0 EU/mg as determined by the LAL method
Storage This low endotoxin antibody is stable when stored at 2-8°C for at least four (4) weeks. For long-term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
Applications Blocking, Flow Cytometry, IHC Frozen, in vivo, Western Blotting
Use Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Write Your Own Review
You're reviewing:Anti-Mouse CD252 (RM134L) In Vivo Antibody - Low Endotoxin
Your Rating
Who Viewed This Also Viewed
Bulk Anti-Human CD45RO (UCHL-1) Antibody
Bulk Anti-Human CD45RO (UCHL-1) Antibody
$390.00 - $2,885.00
Bulk Human IgG1 (IB1) Isotype Control D265A
Bulk Human IgG1 (IB1) Isotype Control D265A
$306.00 - $5,100.00
Tabalumab Biosimilar - Research Grade
Tabalumab Biosimilar - Research Grade
$306.00 - $19,500.00
Selicrelumab Biosimilar - Research Grade
Selicrelumab Biosimilar - Research Grade
$306.00 - $19,500.00
Pucotenlimab Biosimilar - Research Grade
Pucotenlimab Biosimilar - Research Grade
$695.00 - $19,500.00
Otlertuzumab Biosimilar - Research Grade
Otlertuzumab Biosimilar - Research Grade
$306.00 - $19,500.00
Human IgG1 Isotype Control E356D/M358L
Human IgG1 Isotype Control E356D/M358L
$306.00 - $5,100.00
Etokimab Biosimilar - Research Grade
Etokimab Biosimilar - Research Grade
$306.00 - $19,500.00
Odronextamab Biosimilar - Research Grade
Odronextamab Biosimilar - Research Grade
$357.00 - $19,500.00
Ocrelizumab Biosimilar - Research Grade
Ocrelizumab Biosimilar - Research Grade
$732.00 - $19,500.00
Back to Top